Skip To Main Content
Claire Barnard on Muck Rack

Claire Barnard

London
As seen in: Nucleus Global, Biomed Central (BMC), Design Week, Physiological Reports, Montana Kaimin, Medicine Matters Diabetes, Medicine Matters Oncology, Medicine Matters Rheumatology, medwireNews
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Claire

Contact Claire, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Loos – The Forgotten Space

|
By Claire Barnard
| Design Week Verified
In hospitality design, we obsess over the entrance, the bar, the lighting over the tables, and the theatre of the open kitchen. Yet one of the most humble, revealing spaces in any venue is frequently treated as an afterthought: the loos. Step out of a beautifully designed dining room and down a poorly lit corridor to a tired bathroom, and the illusion can quickly collapse.
Open in Who Shared Issue with article?

Say bye to AI

|
By Claire Barnard
| Montana Kaimin Verified
Artificial intelligence keeps getting better, and with it, we’re falling for things more and more, such as a fake leaked audio of Vice President JD Vance dissing tech billionaire Elon Musk that went viral last week. The audio sounds like it was recorded in a room with Vance, and he’s just chatting with a trusted confidant. When I listened to it, I almost fell for it too.
Open in Who Shared Issue with article?

Anti-dsDNA antibodies could predict response to B cell-targeted therapies in SLE

|
By Claire Barnard
| medwireNews Verified
medwireNews: Immunoglobulin (Ig)A2 anti-double stranded DNA (dsDNA) antibodies may represent a biomarker of response to B cell-targeted therapies in patients with systemic lupus erythematosus (SLE), suggest study findings from Michael Ehrenstein (University College London, UK) and colleagues.
Open in Who Shared View Duplicates (3) Issue with article?
See all 2,409 articles